Health and Healthcare

Short Sellers Take Mixed Stance on Major Pharma

Thinkstock

The short interest data have been released for the May 13 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study come back negative or a candidate not be approved. Conversely, if a drug is approved or passes a clinical trial, there can be big upside.

The May 13 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.

Pfizer Inc. (NYSE: PFE) saw its short interest drop to 84.20 million shares from the previous 108.39 million. Shares of Pfizer closed Tuesday at $34.10, within a 52-week trading range of $28.25 to $36.46.

Merck & Co. Inc. (NYSE: MRK) had a slight increase in short interest to 27.87 million shares from 27.68 million in the previous period. Merck shares closed Tuesday at $55.60, in a 52-week range of $45.69 to $61.70.


Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) short interest increased to 26.20 million shares. The previous level was 24.61 million. The current level is the highest in the past 52 weeks. Shares of Teva closed Tuesday at $51.89, in a 52-week range of $49.51 to $72.31.

Bristol-Myers Squibb Co. (NYSE: BMY) saw its short interest decrease to 17.59 million shares from the previous reading of 19.64 million. Shares closed Tuesday at $71.23, within a 52-week range of $51.82 to $73.06.

AbbVie Inc. (NYSE: ABBV) short interest increased to 28.10 million shares, compared to the previous level of 20.99 million. Shares of AbbVie closed Tuesday at $60.70, in a 52-week trading range of $45.45 to $71.60.

The Average American Has No Idea How Much Money You Can Make Today (Sponsor)

The last few years made people forget how much banks and CD’s can pay. Meanwhile, interest rates have spiked and many can afford to pay you much more, but most are keeping yields low and hoping you won’t notice.

But there is good news. To win qualified customers, some accounts are paying almost 10x the national average! That’s an incredible way to keep your money safe and earn more at the same time. Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 3.80% with a Checking & Savings Account today Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.

Click here to see how much more you could be earning on your savings today. It takes just a few minutes to open an account to make your money work for you.

 

Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 4.00% with a Checking & Savings Account from Sofi. Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.

1 https://www.fdic.gov/national-rates-and-rate-caps

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.

AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.